Newhold Investment Corp IV

Newhold Investment Corp IV (NHIV) Financials

$9.950

0.000 (0.00%)At close

NHIV Comparative Benchmarking

In the context of the broader market, NHIV competes directly with industry leaders such as MUZE and SOUL. With a market capitalization of $273.33M, it holds a significant position in the sector. When comparing efficiency, NHIV's gross margin of N/A stands against MUZE's N/A and SOUL's N/A. Such benchmarking helps identify whether Newhold Investment Corp IV is trading at a premium or discount relative to its financial performance.

Newhold Investment Corp IV Financial Performance

The financial performance shows a recent positive net income of $854,000 in Q2 2026, following losses in the previous quarters. The current ratio is strong at 4.07, indicating good short-term financial health. However, total equity has fluctuated significantly, moving from negative to over $196 million, which may raise concerns about stability.

Financials

FY2026Q2
0.00
Total Revenue
FY2026Q2
-619.00K
Operating Profit
FY2026Q2
854.00K
Net Income after Tax
FY2026Q2
0.04
EPS - Diluted
FY2026Q2
-531.00K
Free Cash Flow

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading